VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes

Microvascular Research

Volumn 80, Issue 3, 2010, Pages 372-383

  Yamaji, Maiko ^a   Bielby, Holli ^a   Licence, Di ^a   Cheng, Ching wen ^a   Cook, Emma ^a   Smith, Stephen K ^a   Print, Cristin G ^a   Charnock Jones, D Stephen ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b The Rosie Hospital ^*  (United Kingdom)

Author keywords

Aging; Endothelial and haematopoietic VEGF; Kidney

Indexed keywords

VASCULOTROPIN A;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INCLUSION; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; FEMALE; GENE DOSAGE; HEMATOPOIETIC CELL; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE;

AGE FACTORS; AGING; ANIMALS; ATROPHY; BIOLOGICAL MARKERS; CELL LINEAGE; ENDOTHELIAL CELLS; FEMALE; FIBROSIS; GENOTYPE; HEMATOPOIETIC STEM CELLS; INCLUSION BODIES; KIDNEY; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS;

EID: 78249243381     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.07.006     Document Type: Article

References (54)

1. Abbate M., et al. The microtubule network of renal epithelial cells is disrupted by ischemia and reperfusion. Am. J. Physiol. 1994, 267:F971-F978.
2. Abrass C.K., et al. Aging-associated changes in renal extracellular matrix. Am. J. Pathol. 1995, 146:742-752.
3. Baffert F., et al. Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ. Res. 2004, 94:984-992.
4. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J. Clin. Invest. 1994, 94:1823-1829.
5. Carmeliet P., et al. Abnormal blood vessel development and lethality in embryos lacking a single Vegf-allele. Nature 1996, 380:435-439.
6. Casella I., et al. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 2003, 101:1316-1323.
7. Chen S., et al. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 2004, 53:2939-2949.
8. Choi Y.J., et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum. Pathol. 2000, 31:1491-1497.
9. Coresh J., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003, 41:1-12.
10. Coultas L., et al. Endothelial cells and VEGF in vascular development. Nature 2005, 438:937-945.
11. Croker B.A., et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004, 20:153-165.
12. de Cavanagh E.M., et al. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J. 2003, 17:1096-1098.
13. Eremina V., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 2003, 111:707-716.
14. Eremina V., et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J. Am. Soc. Nephrol. 2006, 17:724-735.
15. Eremina V., et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J. Med. 2008, 358:1129-1136.
16. Esser S., et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 1998, 140:947-959.
17. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581-611.
18. Ferrara N., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
19. Gagliano N., et al. Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:B365-B372.
20. Georgiades P., et al. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 2002, 34:251-256.
21. Gerber H.P., et al. VEGF is required for growth and survival in neonatal mice. Development 1999, 126:1149-1159.
22. Gerber H.P., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002, 417:954-958.
23. Guan F., et al. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am. J. Physiol. Ren. Physiol. 2006, 291:F422-F428.
24. Haramoto T., et al. Ultrastructural localization of three major basement membrane components - type IV collagen, heparan sulfate proteoglycan and laminin in the normal human GBM. Nippon Jinzo Gakkai Shi 1993, 35:933-939.
25. Iruela-Arispe L., et al. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am. J. Pathol. 1995, 147:1715-1727.
26. Kamba T., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H560-H576.
27. Kanellis J., et al. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am. J. Physiol. Ren. Physiol. 2000, 278:F905-F915.
28. Kang D.H., et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am. J. Kidney Dis. 2001, 37:601-611.
29. Kang D.H., et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 2002, 13:806-816.
30. Kang D.H., et al. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am. J. Pathol. 2004, 164:679-688.
31. Kim B.S., et al. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J. Am. Soc. Nephrol. 2002, 13:2027-2036.
32. Kimura M., et al. Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model. Nephrol. Dial. Transplant. 2005, 20:1559-1565.
33. Kitamoto Y., et al. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J. Clin. Invest. 1997, 99:2351-2357.
34. Lambrechts D., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003, 34:383-394.
35. Lee S., et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703.
36. Long D.A., et al. Blood vessels and the aging kidney. Nephron Exp. Nephrol. 2005, 101:e95-e99.
37. Mastroeni P., et al. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect. Immun. 1995, 63:3674-3682.
38. Masuda Y., et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol. 2001, 159:599-608.
39. Meyrier A., et al. Ischemic renal diseases: new insights into old entities. Kidney Int. 1998, 54:2-13.
40. Noguchi K., et al. Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis. J. Am. Soc. Nephrol. 1998, 9:1815-1825.
41. Ogilvy S., et al. Promoter elements of Vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood 1999, 94:1855-1863.
42. Oosthuyse B., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001, 28:131-138.
43. Qiu Y., et al. The anti-angiogenic isoforms of VEGF in health and disease. Biochem. Soc. Trans. 2009, 37:1207-1213.
44. Ricono J.M., et al. Morphological insights into the origin of glomerular endothelial and mesangial cells and their precursors. J. Histochem. Cytochem. 2003, 51:141-150.
45. Sands J.M. Urine-concentrating ability in the aging kidney. Sci. Aging Knowl. Environ. 2003, PE15.
46. Shimizu A., et al. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am. J. Pathol. 1997, 151:1231-1239.
47. Simon M., et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 1995, 268:F240-F250.
48. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
49. Tang N., et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven Vegf-autocrine loop necessary for tumorigenesis. Cancer Cell 2004, 6:485-495.
50. Thomas S.E., et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J. Am. Soc. Nephrol. 1998, 9:231-242.
51. Thomas S., et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J. Am. Soc. Nephrol. 2000, 11:1236-1243.
52. Yabuki A., et al. Effects of sex hormones on the development of giant lysosomes in the proximal tubules of DBA/2Cr mouse kidney. J. Anat. 2003, 202:445-452.
53. Yamada H., et al. Age-associated changes in ammoniagenesis in isolated rat renal tubule segments. Am. J. Physiol. 1992, 262:F600-F605.
54. Zeisberg M., et al. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 2000, 13(Suppl 3):S111-S120.